Search Results 241-250 of 7067 for younkin

  1. Anja M. Kinaszczuk, D.O. - Doctors and Medical Staff - Mayo Clinic

    Awards and honors · 2023. 2022 Mayo Clinic Experience Top Performer AwardMayo Clinic in Florida · 2022. 2021 Mayo Clinic Experience Top Performer AwardMayo Clinic ...

  2. https://www.mayoclinic.org/procedure_concepts.xml

  3. To Assess the Effectiveness, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Evaluation of patients perceived health and fitness prior to surgery during the COIVD 19 pandemic - Mayo Clinic

    The primary aim of this study is to assess colon and rectal surgery patient perceptions of physical fitness, willingness to participate in a prehabilitation ...

  5. Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery - Mayo Clinic

    Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving pembrolizumab, combination chemotherapy, and radiation therapy before ...

  6. Diffusion Tensor Imaging of the Thalamus - Mayo Clinic

    About this study. The purpose of this study is to inform more precise neurosurgical interventions by localizing specific white matter structures.

  7. A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough - Mayo Clinic

    The purpose of this study is to determine the effectiveness of three doses of orvepitant, taken once a day, in the treatment of chronic refractory cough.

  8. Focus Areas - Phospholipid Signaling in Embryonic Development and Human Diseases: Kun Ling - Mayo Clinic Research

    Learn how Dr. Ling's Phospholipid Signaling in Embryonic Development and Human Diseases Lab at Mayo Clinic studies the roles of phosphoinositide species and ...

  9. A Study to Evaluate the Safety and Tolerability of DCC-2618 in Patients with Advanced Malignancies - Mayo Clinic

    This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics ...

  10. EHR-Based Genomic Discovery - Atherosclerosis and Lipid Genomics Laboratory - Mayo Clinic Research

    The research team in Dr. Kullo's Atherosclerosis and Lipid Genomics Laboratory is conducting electronic health record (EHR)-based genetic studies.